CA
TEVA icon

Commerzbank Aktiengesellschaft’s Teva Pharmaceuticals TEVA Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-57,700
Closed -$392K – 1011
2019
Q2 		$392K Buy
+57,700
New +$696K ﹤0.01% 795
2019
Q1 		– Sell
-200,000
Closed -$426K – 978
2018
Q4 		$426K Hold
200,000
– – ﹤0.01% 692
2018
Q3 		$114K Buy
+200,000
New +$4.64M ﹤0.01% 907

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commerzbank Aktiengesellschaft's TEVA Position: Q2 2020 in Review

Commerzbank Aktiengesellschaft sold out of Teva Pharmaceuticals (TEVA) in Q2 2020, closing a stake of 393,552 shares — an estimated $3.53M sold.

Commerzbank Aktiengesellschaft first reported a position in TEVA in Q2 2013 and held it in 28 quarters. The position peaked at $77.4M in Q4 2019. 455 funds tracked by Wall St. Rank hold TEVA as of Q2 2020.

  • Commerzbank Aktiengesellschaft reported no remaining Teva Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 393,552 Teva Pharmaceuticals shares in Q2 2020, an estimated $3.53M.
  • Commerzbank Aktiengesellschaft first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 28 quarters.
  • Commerzbank Aktiengesellschaft's Teva Pharmaceuticals position peaked at $77.4M in Q4 2019.
  • 455 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2020.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2020, filed 21 Jul 2020.